APPLICATION OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO BOSUTINIB PHARMACOKINETICS: PREDICTION OF DRUG-DISEASE INTERACTION IN ORGAN DYSFUNCTION PATIENTS.

Ono C.; Hsyu P.; Abbas R.; Loi C.; Yamazaki S.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >APPLICATION OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO BOSUTINIB PHARMACOKINETICS: PREDICTION OF DRUG-DISEASE INTERACTION IN ORGAN DYSFUNCTION PATIENTS.

【24h】

APPLICATION OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO BOSUTINIB PHARMACOKINETICS: PREDICTION OF DRUG-DISEASE INTERACTION IN ORGAN DYSFUNCTION PATIENTS.

机译：基于生理的药代动力学模型在波司替尼药代动力学中的应用：预测器官功能障碍患者中的药物-疾病相互作用。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2015年第s1期|共1页
作者
Ono C.; Hsyu P.; Abbas R.; Loi C.; Yamazaki S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. APPLICATION OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO BOSUTINIB PHARMACOKINETICS: PREDICTION OF DRUG-DISEASE INTERACTION IN ORGAN DYSFUNCTION PATIENTS. [J] . Ono C., Hsyu P., Abbas R., Clinical Pharmacology and Therapeutics . 2015,第S1期

机译：基于生理的药代动力学模型在波司替尼药代动力学中的应用：预测器官功能障碍患者中的药物-疾病相互作用。
2. Potential for pharmacokinetic interactions between Schisandra sphenanthera and bosutinib, but not imatinib: in vitro metabolism study combined with a physiologically-based pharmacokinetic modelling approach [J] . Adiwidjaja Jeffry, Boddy Alan V., McLachlan Andrew J. British Journal of Clinical Pharmacology . 2020,第10期

机译：Schisandra Sphenanthera和Bosutinib之间的药代动力学相互作用，但不是伊马替尼：体外代谢研究与生理学上的药代动力学建模方法相结合
3. A Minimal Physiologically-Based Pharmacokinetic Model Demonstrates Role of the Neonatal Fc Receptor (FcRn) Competition in Drug-Disease Interactions With Antibody Therapy [J] . Abdallah Hussein M., Zhu Andy Z. X. Clinical Pharmacology and Therapeutics . 2020,第2期

机译：基于生理学的药代动力学模型最小的基于生理学的药代动力学模型表明了新生儿FC受体（FCRN）竞争与抗体治疗的毒性相互作用的作用
4. Bayesian inference and model selection for physiologically-based pharmacokinetic modeling of superparamagnetic iron oxide nanoparticles [C] . Lynn Bi, Javad Sovizi, Kelsey Mathieu, SPIE Medical Imaging Conference . 2018

机译：基于贝叶斯推断和模型选择的超顺磁性氧化铁纳米粒子的生理基础药代动力学
5. Applications of Physiologically Based Pharmacokinetic Modelling to Prediction of the Likelihood of Metabolic Drug Interactions in Paediatric Population and Studying Disparities in Pharmacokinetics Between Children and Adults [D] . Salem, Farzaneh. 2014

机译：基于生理的药代动力学模型在小儿人群中代谢药物相互作用的可能性预测和研究儿童与成人之间药代动力学差异的应用
6. A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1 OCT1 OCT2 and CYP2C8 Drug–Drug–Gene Interaction Predictions [O] . Denise Türk, Nina Hanke, Thorsten Lehr 2020

机译：Mate1Oct1Oct2和CYP2C8药物 - 药物 - 基因相互作用预测预测的一种生理学上的基于Trimethokim的药代动力学模型
7. Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug–Drug and Drug–Disease Interactions [O] . Chiho Ono, Poe-Hirr Hsyu, Richat Abbas, 2017

机译：基于生理学的药代动力学模拟在博斯托尼药代动力学理解中的应用：毒品 - 药物和毒性疾病相互作用的预测
8. Providing a Theoretical Basis for Nanotoxicity Risk Analysis Departing from Traditional Physiologically-Based Pharmacokinetic (PBPK) Modeling [R] . Yamamoto, D. P. 2010

机译：为传统的基于生理学的药代动力学（pBpK）建模的纳米毒性风险分析提供理论基础

APPLICATION OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO BOSUTINIB PHARMACOKINETICS: PREDICTION OF DRUG-DISEASE INTERACTION IN ORGAN DYSFUNCTION PATIENTS.

著录项

相似文献

相关主题

期刊订阅